Pharmaceutical process engineers are vital professionals who design, optimize, and scale up the manufacturing processes of pharmaceutical products. Their main focus is to ensure that drug production is efficient, cost-effective, and meets stringent quality standards. These engineers apply principles of chemical engineering, mechanical engineering, and pharmaceutics to develop processes that convert raw materials into finished dosage forms, such as tablets, capsules, injectables, or ointments. By carefully controlling parameters like temperature, pressure, mixing speed, and drying conditions, pharmaceutical process engineers help maintain consistency, purity, and potency of the medications. They also work to enhance production yield, minimize waste, and comply with regulatory requirements, making their role crucial in bringing safe and effective drugs to the market.
Beyond process design, pharmaceutical process engineers are deeply involved in troubleshooting manufacturing challenges, implementing process analytical technologies (PAT), and advancing continuous manufacturing techniques to improve efficiency and reduce costs. Their expertise is critical in technology transfer between research and development (R&D) and commercial manufacturing sites. Additionally, they collaborate closely with quality assurance teams to validate processes and ensure compliance with good manufacturing practices (GMP). As the pharmaceutical industry evolves with emerging technologies and stricter regulations, pharmaceutical process engineers remain essential for optimizing production workflows, enhancing product quality, and ensuring the timely delivery of life-saving medicines worldwide.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico